Dr REBECCA TRUEMAN
| Post Nominals | BSc(Hons) PhD AFHEA |
|---|---|
| Biography | I have a background in biological sciences, with a focus on neuroscience, and have been working on phenotyping rodent models of disease for over 20 years. My current focus is on models of myotonic dystrophy, and I have a growing interest in CDK12 and CDK13 knock-out and mutation models. Over my career, I have worked with transgenic mouse models and surgical models of Huntington’s disease, stroke and myotonic dystrophy. I have a keen interest in improving the standards of preclinical research, and as such set up and co-organised the inaugural UK Preclinical Stroke Symposium for 10 years. I am also a member of the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) working group on animal models of stroke which published the IMPROVE guidelines for rodent stroke studies. With my expertise in in vivo studies I have been co-managed, as Co-investigator, the in vivo aspects of large collaborative grants from the MRC (DPFS, £2.4 million) and Wellcome Trust (Seeding drug discovery, £3 million), as well as managing PI grants. |
| Scopus Author ID | 8595668900 |